Christophe Pouchoy, Managing Director and Managing Director of Trecento Asset Management, analyzed the boom in homeopathy in the Challenges magazine.
“With 24% of turnover in 2017 for promotional expenses – and less than 1% for research expenses – Boiron has the (…)”
Read the article by clicking here (available in French only)
